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Abstract 
Problem: To characterize the amniotic fluid (AF) inflammatory-related protein (IRP) network in 
patients with a sonographic short cervix (SCx) and to determine its relation to early preterm 
delivery (ePTD).  
Method of Study: A retrospective cohort study included women with a SCx (≤25mm) (n=223) 
who had amniocentesis and were classified according to gestational age (GA) at diagnosis and at 
delivery (ePTD <32 weeks of gestation).  
Results: 1) In women with a SCx <22 1/7 weeks, the concentration of most IRPs increased as 
the cervix shortens; those with ePTD had a higher rate of increase of MIP-1a, MCP-1 and IL-6 
concentrations than those delivering later; 2) concentration of most IRPs, and correlation 
between several IRP pairs, was higher in the ePTD group vs. those delivering later.  
Conclusions:
 
  Women with a SCx at 16 to 22 1/7 weeks have a unique AF cytokine network 
correlating with cervical length at diagnosis and GA at delivery. This network may assist in 
predicting ePTD. 
 
Keywords:
 
 amniocentesis, cervical insufficiency, cytokine, macrophage inflammatory protein 
(MIP), monocyte chemoattractant protein-1 (MCP), network analysis, preterm birth 
Running Head: AF Cytokine Network in Women with Short Cervix 
 
A sonographic short cervix is a strong predictor of spontaneous preterm delivery (
Introduction  
1-15). The 
earlier the diagnosis of a short cervix, the more likely the patient will deliver preterm (16-33). 
Compelling evidence supports the view that this condition is syndromic in nature and has 
multiple etiologies (34, 35, 13, 36, 37), such as a decline in progesterone action (38-48), prior 
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cervical surgery (49-57), intra-amniotic inflammation and/or infection (58-63), and genuine 
cervical insufficiency (35, 64). Patients with a mid-trimester sonographic short cervix can be 
offered treatment with vaginal progesterone (65-73) and, for those with a history of prior preterm 
birth, a cervical cerclage (74-80) may be placed.  
A subset of patients with a mid-trimester sonographic short cervix [cervical length (CL) ≤ 25 
mm] may have microbial invasion of the amniotic fluid (MIAC) with or without inflammation 
(62, 81, 82). A sterile intra-amniotic inflammation appears to be more common than MIAC (10% 
versus 2.2%, respectively) and is associated with an increased risk of spontaneous preterm 
delivery <34 weeks of gestation (82). The presence of intra-amniotic inflammation (both 
microbial and sterile) is associated with adverse pregnancy outcomes (83-89, 35, 90, 91) in 
patients presenting with preterm labor and intact membranes (92-108), preterm prelabor rupture 
of the membranes (PPROM) (109-114), a sonographic short cervix (115, 60, 62, 82), and 
cervical insufficiency (58, 59, 116, 64, 117).Thus, we and others have explored the behavior of 
cytokines and other inflammatory-related markers in amniotic(100, 118, 119, 106, 120-123, 107, 
82, 108, 124-128) or vaginal (129-140) fluid. 
Disease states are generally caused by the interaction of a group of correlated molecules (or 
network) and not by the effect of a single or individual molecule (141-147). For example, in the 
context of inflammation, one cytokine can induce the expression of others, which can modulate 
the immune response and lead to the development of feedback regulatory networks (148). Thus, 
in order to understand the pathogenesis of inflammatory-related diseases, cytokines should 
ideally be studied as groups of interacting molecules/proteins (149-151). Indeed, recent evidence 
suggests that biomarkers derived from network analysis are able to achieve better diagnostic 
performance than those derived using a single-molecule approach (152-155, 61, 156, 157, 148, 
158).  
Women with microbial-associated or sterile intra-amniotic inflammation had a more coordinated 
cytokine network than those without intra-amniotic inflammation (127). By using a network 
approach, we were able to demonstrate that microbial and sterile intra-amniotic inflammation 
differ in their cytokine networks (127). Therefore, the objective of this study was to examine the 
amniotic fluid inflammatory-related protein network in asymptomatic patients with a mid-
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trimester sonographic short cervix according to gestational age at the time of diagnosis and 
delivery.  
Study population  
Materials and methods 
A retrospective cohort study was conducted to include 223 patients with an asymptomatic 
sonographic short cervix. Amniotic fluid samples of participants were selected from the clinical  
database and Bank of Biological Materials of Wayne State University, the Detroit Medical 
Center, and the Perinatology Research Branch of the Eunice Kennedy Shriver National Institute 
of Child Health and Human Development (NICHD) if the patients met the following criteria: 1) 
singleton gestation; 2) asymptomatic sonographic cervical length ≤25 mm; 3) transabdominal 
amniocentesis performed for molecular microbiological studies; and 4) available pregnancy 
outcomes. Exclusion criteria were: 1) rupture of membranes or preterm labor symptoms before 
amniotic fluid collection; 2) chromosomal or structural fetal anomaly; or 3) placenta previa. A 
subset of patients in the current study was included in a prior study (82), which provides 
description of the molecular microbiologic findings of the amniotic cavity and amniotic fluid IL-
6 concentrations. All patients provided written informed consent, and the use of biological 
specimens as well as clinical and ultrasound data for research purposes was approved by the 
Institutional Review Boards of Wayne State University and NICHD.  
Clinical definitions, methods of sonographic assessment of the cervix, sample collection, and the 
detection of microorganisms as well as amniotic fluid IL-6 concentrations were previously 
reported (82). Briefly, spontaneous preterm labor was defined by the presence of regular uterine 
contractions occurring at least twice every 10 minutes, associated with cervical changes before 
37 completed weeks of gestation. Early spontaneous preterm delivery was defined as 
spontaneous preterm delivery before 32 completed weeks of gestation. Patients classified as 
having spontaneous preterm delivery included those with spontaneous preterm labor, preterm 
prelabor rupture of the membranes (PPROM), and those whose labor was induced or augmented 
due to clinical chorioamnionitis (159). Patients who were lost to follow-up or who had 
unavailable delivery data were censored.  
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Intra-amniotic inflammation was characterized by an amniotic fluid IL-6 concentration ≥2.6 
ng/mL (100, 118, 106, 120, 122, 123, 107, 82, 108, 124, 114). Microbial invasion of the amniotic 
cavity was defined according to the results of amniotic fluid culture and broad-range polymerase 
chain reaction (PCR) coupled with electrospray ionization mass spectrometry (PCR/ESI-MS) 
analysis (105, 113). Acute histologic chorioamnionitis was diagnosed based on the presence of 
inflammatory cells in the chorionic plate and/or chorioamniotic membranes, and acute funisitis 
was diagnosed by the presence of neutrophils in the wall of the umbilical vessels and/or 
Wharton’s jelly, using previously described criteria (86, 160-169). 
Multiplex determination of inflammatory-related proteins 
Amniotic fluid concentrations of 33 inflammatory-related proteins were determined using a 
multiplex bead array assay developed by the investigators as previously described in detail (see 
Supplementary Methods) (127). 
Statistical analysis 
The goal of the statistical analysis was to a) assess the relation between the risk of preterm 
delivery and gestational age at amniocentesis, b) assess the relation between inflammatory-
related protein concentration and cervical length, c) evaluate differences in inflammatory-related 
protein concentration between groups (delivery ≤32 or >32 weeks of gestation) and d) evaluate 
differences in correlation of pairs of proteins between groups and build correlation networks. To 
accomplish these goals, women were divided into three groups based on the gestational age at 
amniocentesis with the two cut-off points representing tertiles of the distribution: 16 5/7 to 22 
1/7, 22 2/7 to 26 1/7, and 26 2/7 to 31 5/7 weeks of gestation. In addition to creating equal-sized 
subgroups of patients, this sub-classification of samples is based on i) previous observations that 
the populations of patients diagnosed with short cervix are different depending whether or not 
the diagnosis is made earlier as opposed to later in gestation (81) and also on ii) the observation 
that pro-inflammatory protein concentrations may vary with gestational age at 
amniocentesis(127).  
The association between the interval of gestational age at amniocentesis and risk of preterm 
delivery was tested using a chi-squared test for trend in proportions. To test for differential 
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analyte concentration between groups within each gestational age interval, a linear model was fit 
to the log (base 2) of analyte concentration as a function of the group indicator (patient delivered 
≤32 or >32 weeks of gestation) while adjusting for gestational age at amniocentesis. Similarly, to 
test the association between analyte concentration and cervical length, a linear model was fit to 
log (base 2) of analyte concentration as a function of cervical length and the group indicator 
(patient delivered ≤32 or >32 weeks of gestation)  while adjusting for the gestational age at 
amniocentesis. An interaction term was allowed between the group indicator and cervical length 
to accommodate possible differences in the rate of change of analyte concentration with cervical 
length between groups.   
 Significance test p values for the group (delivery ≤32 or >32 weeks of gestation) coefficient as 
well as for the cervical length coefficient were adjusted with the Benjamini-Hochberg method 
over all 33 analytes to compute q-values. Significance of differences in concentration was 
determined based on a q-value <0.1 and a fold change >1.5. For changes with cervical length, the 
minimum fold change cut-off of 1.5 was defined over 1cm change in cervical length.  
The difference in concentration correlation of each possible pair of analytes (e.g., IL-1α and IL-
6, IL-1α and IL-33, etc.) between groups was assessed as follows. A linear model was fit to the 
log-transformed data of each protein as a function of gestational age using samples of each group 
separately in each gestational-age interval. The residuals (actual value - fitted value) were then 
used to compute the Pearson correlation for each pair of analytes (called partial correlations). To 
test for differences in partial correlations between groups within each interval, the partial 
correlations were first converted into an intermediary statistic using Fisher’s z transformation. 
Under the null hypothesis (partial correlations are equal between groups), the standardized 
differences in z values among groups were assumed to follow a standard normal distribution. 
Significant differences in partial correlations were inferred based on p<0.01 and the magnitude 
of correlation differences was at least 0.2.  
A network of differential correlation between groups of women was constructed for each 
gestational-age interval by linking/connecting the proteins with significant differences in partial 
correlations (also referred to as perturbed correlation). For each node (protein) in the network, 
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we calculated the degree (number of perturbed correlation of a given protein), and the average 
absolute difference in correlations as previously described (127).  
To identify confounding variables that could impact the analyses described above, we have used 
Chi-square tests to determine the association of covariates (administration of steroids, antibiotics, 
and progesterone before amniocentesis) and preterm delivery within each interval. Covariates 
with significant association with the outcome were adjusted for in the differential concentration 
and differential correlation analyses. 
Characteristics of the study population 
Results 
Two hundred twenty-three patients who had a sonographic short cervix (≤25 mm) were included 
in this study. Demographic and clinical characteristics of the study population are displayed in 
Table 1. The median gestational age at amniocentesis was 24 3/7 weeks. Forty-four percent 
(99/223) of patients with a short cervix delivered at term. Most patients did not have intra-
amniotic inflammation [75.3% (168/223)]. Among patients with intra-amniotic inflammation, the 
frequency of sterile intra-amniotic inflammation was higher than microbial-associated intra-
amniotic inflammation [10.3% (23/223) and 2.2% (5/223), respectively] (Table 1). Patients with 
a sonographic short cervix were classified according to gestational age at delivery, and 28.7% 
(64/223) delivered ≤32 weeks of gestation while the remaining 71.3% (159/223) delivered >32 
weeks of gestation.  
The samples included in this study were collected before the publication of randomized trials 
reporting that vaginal progesterone reduces the rate of preterm delivery and neonatal morbidity; 
therefore, none of our patients received vaginal progesterone. Eight percent (18/221) of patients 
underwent cerclage. There were no significant differences in the frequencies with which 17-
alpha-hydroxyprogesterone caproate, antibiotic, and antenatal corticosteroids were administered 
within 7 days before amniocentesis between women with a short cervix who delivered ≤32 
weeks of gestation and those who delivered >32 weeks of gestation (Table 1). 
The prevalence of intra-amniotic inflammation (defined as amniotic fluid IL-6 concentration 
≥2.6 ng/mL) including both microbial-associated and sterile intra-amniotic inflammation, was 
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significantly higher in patients with a sonographic short cervix who delivered ≤32 weeks of 
gestation than in those who delivered >32 weeks of gestation (p<0.05 for all; Table 1). 
Additionally, the median amniotic fluid IL-6 concentrations (ng/mL) and the frequency of acute 
inflammatory lesions of the placenta were significantly higher and more frequent in patients with 
a short cervix who delivered ≤32 weeks of gestation than in those who delivered >32 weeks of 
gestation [IL-6: median (IQR); 1.11 (0.31-4.15) vs. 0.59 (0.28-0.99); p=0.002; acute 
inflammatory lesion of the placenta: 73.3% (44/60)  vs. 33.3% (48/144); p<0.001; Table 1].   
The risk of preterm delivery according to the presence of a sonographic short cervix and 
gestational age at diagnosis 
Patients with a short cervix who delivered ≤32 weeks of gestation had a significantly lower 
gestational age at amniocentesis/ at diagnosis with a short cervix and they had a shorter 
sonographic cervical length than those who delivered >32weeks of gestation (p <0.001 for all; 
Table 1). When patients were stratified according to the tertiles of gestational age at 
amniocentesis, the rate of delivery at ≤32 was 50% in those with asymptomatic short cervix 
identified at 16 5/7 - 22 1/7, 21% in those identified at 22 2/7 - 26 1/7, and 15% in those at 26 
2/7-31 5/7 weeks of gestation (Chi-squared test for trend p<0.0001). 
We examined whether the administration of steroids, antibiotics, and progesterone before 
amniocentesis could have had a confounding effect on the differential concentration analysis of 
proteins. The association of these covariates with the “group indicator” (whether a patient 
delivered ≤32 or >32 weeks of gestation) in each gestational age interval at amniocentesis was 
assessed and was found to be significant (p=0.014) only for steroids in the gestational age 
window between 26 2/7 and 31 5/7 weeks interval of gestational age at amniocentesis. Therefore, 
we adjusted for exposure to steroids in the third interval of gestational age at amniocentesis and 
found little effect on the differential concentration and correlation analysis results, as described 
below. 
Potential effects of confounding variables  
 
The inflammatory protein concentrations and sonographic cervical length 
Au
th
or
 M
an
us
cr
ip
t
10 
 
This article is protected by copyright. All rights reserved 
We have tested the association between inflammatory-related protein concentrations and cervical 
length within the group of patients in which the diagnosis with short cervix/ gestational age at 
amniocentesis was made early in pregnancy (16 5/7 - 22 1/7 weeks) while controlling for the 
gestational age at amniocentesis. This set of patients include an equal number of deliveries at ≤32 and >32 weeks of gestation. The concentration of all inflammatory-related proteins were 
inversely related to cervical length (i.e. the shorter the cervix, the higher the concentration the 
proteins) (q<0.1 for all). Only IP-10 and IL-18 did not reach the required minimum of 1.5 fold 
change in abundance per cm change in cervical length to be considered statistically significant. 
Fold changes for significant proteins ranged from 1.5 to 8.5 fold per cm (IL-33 and IL-8, 
respectively) (see Figure 1 and Table 2). For three proteins (MIP-1α, MCP-1, IL-6) the rate of 
change in abundance with cervical length was higher in patients who delivered at ≤32 weeks 
compared to those who delivered at >32 weeks of gestation (Figure 2). 
Differences in amniotic fluid inflammatory-related protein concentrations between patients 
with a sonographic short cervix who delivered before and after 32 weeks of gestation  
The amniotic fluid concentrations of 33 inflammatory-related proteins were compared between 
patients with a sonographic short cervix who delivered ≤32 and >32 weeks of gestation. Since 
the amniotic fluid concentration of these analytes has a non-linear relationship with gestational 
age and their discriminatory power may vary as a function of duration of pregnancy, we assessed 
differential concentration within three separate intervals and adjusting for gestational age at 
amniocentesis.  
All inflammatory proteins but five (IL-18, IL-33, IP-10, MIG, and MIP-3α) had a significantly 
higher mean concentrations in patients who delivered ≤32 weeks of gestation than in those who 
delivered >32 weeks of gestation (fold change >1.5; q-value <0.1). The highest changes of 
amniotic fluid protein concentration were observed for IL-8, MIP-1β, IL-6, and IL-10 (5.6, 5.1, 
4.5, and 4.4-fold, respectively) (Table 3). Of the 28 inflammatory-related proteins whose 
concentrations were significantly different between groups in this interval, 18 would remain 
Amniotic fluid concentration of inflammatory proteins in patients with a short cervix diagnosed 
between 16 5/7 and 22 1/7 weeks of gestation 
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significant when the analysis was restricted to patients without intra-amniotic inflammation (see 
highlighted proteins in Table 3).   
 
In this gestational age window, the differences in amniotic fluid concentrations of inflammatory-
related proteins between groups was of a lesser magnitude than those in the first gestational age 
interval (16 5/7 to 22 1/7 weeks); for nine analytes, the mean amniotic fluid concentration was 
significantly higher in patients who delivered ≤32 weeks of gestation compared to those who 
delivered >32 weeks of gestation (fold change >1.5; q-value <0.1). The three analytes with the 
highest concentration were IL-8, IL-6, and MIP-1β (5.4, 4.2, and 2.6-fold, respectively, Table 3). 
Amniotic fluid concentration of inflammatory proteins in patients with a short cervix diagnosed 
between 22 2/7 and 26 1/7 weeks of gestation 
The difference in amniotic fluid concentration of inflammatory-related proteins between groups 
was lesser than that in the other two gestational age groups. The only protein with a significant 
difference in median concentration between patients who delivered ≤32 weeks of gestation 
compared to those who delivered >32 weeks of gestation was IL-8 (fold change of 2.3 and 
nominal p value <0.05, Table 3). However, this significance was lost when adjusting for the 
administration of steroids, which was a confounder variable in the analysis of patients in this 
interval of gestational age (as described above).  
Amniotic fluid concentration of inflammatory proteins in patients with a short cervix diagnosed 
between 26 2/7 and 31 5/7 weeks of gestation 
Amniotic fluid cytokine network analysis according to gestational age at diagnosis of a 
short cervix 
Since the concentration of pro-inflammatory proteins changes with gestational age at 
amniocentesis, (see Figure 3, top panel for IL-10 and MIP-1β) differences in correlation patterns 
of pairs of proteins between groups were assessed within three intervals of gestational age, after 
removing the linear trend with gestational age from log (base 2) protein concentration (Figure 3, 
bottom panel). The example presented in Figure 3 shows that in the interval 16 5/7 and 22 1/7 
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weeks, the partial correlation between MIP-1β and IL-10 is 0.65 in patients who delivered at ≤32 
weeks and only 0.05 in patients who delivered >32 weeks (difference in correlation coefficient of 
0.65-0.05=0.60, p=0.0055, see Table S1).  
Patients with a sonographic short cervix diagnosed between 16 5/7 and 22 1/7 weeks of gestation 
who delivered ≤3 2 weeks of gestation had a higher concentration of inflammatory-related 
proteins than those who delivered >32 weeks of gestation (22 perturbed proteins). IL-8, MIP-1β, 
and MIP-1α had the highest number of perturbed correlations (degrees of 6, 5, and 5, 
respectively), while IL-8, MIP-1β, and IL-6 showed the largest magnitude of change between 
groups (Figure 4A). 
Patients with a sonographic short cervix diagnosed between 22 2/7 and 26 1/7 weeks of gestation 
who delivered ≤32 weeks of gestation had higher correlation among 16 amniotic fluid 
inflammatory-related proteins than those who delivered >32 weeks of gestation (35 perturbed 
correlations). RANTES, IL-8, IL-6, MCP-1, and MIP-1β had the highest number of perturbed 
correlations (degree of 11, 8, 8, 8, and 6, respectively), whereas IL-6 and IL-8 demonstrated the 
highest magnitude of change in concentration (Figure 4B). 
Among patients with a sonographic short cervix diagnosed between 26 2/7 and 31 5/7 weeks of 
gestation who delivered ≤32 weeks of gestation had the less degree of perturbation in correlation 
and expression in amniotic fluid cytokines compared to those who delivered >32 weeks of 
gestation (only 5 perturbed correlations). 
 
 
 
 
Discussion 
Principal findings of the study: 1) The earlier the short cervix was diagnosed, the higher the 
rate of preterm delivery ≤32 weeks of gestation , reaching 50% in the 16 5/7 to 22 1/7 weeks 
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interval; 2) In patients with short cervix diagnosed at 16 5/7 to 22 1/7 weeks, the concentration of 
most inflammatory-related proteins increases as the cervix shortens in both delivery groups, yet 
the rate of increase of MIP-1a, MCP-1 and IL-6 is higher in women who delivered at ≤32 weeks 
compared to those who delivered at >32 weeks of gestation  3) The concentration of most 
inflammatory-related proteins studied herein was higher in patients who delivered at ≤32 weeks 
compared to those who delivered at >32 weeks of gestation, yet the magnitude of the difference 
decreases with increasing gestational age at amniocentesis and diagnosis of a short sonographic 
cervix. 4) The concentration correlation of several pairs of inflammatory-related proteins was 
overall higher in patients who delivered at ≤32 weeks compared to those who delivered at >32 
weeks of gestation.  
Inflammatory-related protein network connectivity of patients who had preterm delivery 
≤32 weeks of gestation and had been diagnosed with a short cervix between 16 and 22 
weeks 
Patients with a sonographic short cervix and a subsequent early preterm delivery had more 
coordinated amniotic fluid cytokine concentrations than those who had late preterm delivery. IL-
8 and MIP-1β are the key mediators derived from both differential correlation and concentration 
analysis. Interestingly, MIP-1α is the top-ranked protein obtained from the differential 
correlation approach despite its small magnitude of change in concentration (fold change=1.56; 
p=0.00016).  
The 2 top-ranked proteins, IL-8 and MIP-1β, obtained from the analysis of both correlation 
network and differential concentration have been implicated in the pathogenesis of intra-
amniotic inflammation/infection in preterm labor (170-172), preterm prelabor rupture of the 
membranes (172), and clinical chorioamnionitis (173). Both IL-8 (neutrophil attractant/activating 
peptide-1) and MIP-1β (CCL4) are chemotactic cytokines that activate neutrophils and other 
human granulocytes in response to inflammation or infection (174, 175). These chemokines are 
mainly produced by macrophages, mononuclear cells, and lymphocytes (176, 175). Previous 
studies demonstrated that amniotic fluid concentrations of IL-8 and MIP-1β increase in patients 
with preterm labor who had intra-amniotic inflammation/infection and clinical chorioamnionitis 
at term with proven intra-amniotic infection, and they can predict the likelihood of spontaneous 
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preterm delivery (177, 170, 171, 178, 172, 179-183).  In addition, both chemokines are 
significantly higher in patients with a mid-trimester short cervix who delivered <34 weeks than 
in those who delivered ≥34 weeks of gestation (155, 148), and their concentrations correlated 
with cervical length (61).  
In contrast, MIP-1α (or CCL-3) is the top-ranked protein identified from correlation analysis but 
not differential concentration analysis. Interestingly, this cytokine has been implicated in the 
pathogenesis of intra-amniotic inflammation/infection in patients with preterm delivery and 
clinical chorioamnionitis (183). MIP-1α is produced by macrophages (184) and activates human 
granulocytes in response to inflammation and infection (185-193). These observations suggest 
that proteins ranked by network correlation analysis are of value and have biological plausibility 
in the pathogenesis of intra-amniotic inflammation/infection in patients with a sonographic short 
cervix, despite having a small magnitude of change from a simple comparison of mean 
concentrations.  
 
Inflammatory-related protein network connectivity between patients who delivered ≤32 
and >32 weeks of gestation with a short cervix diagnosed between 22 2/7 and 26 1/7 weeks 
of gestation 
The top-ranked proteins obtained from differential concentration analysis (IL-8, IL-6, and MIP-
1β) are similar to those derived from correlation analysis. Moreover, IL-8 and MIP-1β are also 
the top-ranked proteins in the network of perturbed inflammatory-related protein concentrations 
between 16 5/7 and 22 1/7 weeks of gestation. RANTES and MCP-1 are the two additional 
proteins that are key mediators during this interval derived from correlation analysis. MCP-1 is 
significantly lower in patients who delivered ≤32 weeks than in those who delivered >32 weeks 
when a sonographic short cervix was diagnosed between 22 2/7 and 26 1/7 weeks of gestation 
(fold change=1.97, p=0.022). The amniotic fluid concentrations of RANTES were not 
significantly different (p=0.156). Interestingly, RANTES had no perturbed correlations of 
inflammatory-related protein concentration in women with a short cervix diagnosed between 16 
5/7 and 22 1/7 weeks, but it had the highest number of perturbed correlations in women with a 
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short cervix diagnosed between 22.2 and 26.1 weeks of gestation (n=11), suggesting that 
gestational age is a factor that may modulate the nature of the cytokine response. 
It is well established that amniotic fluid IL-8, IL-6, and MIP-1β are involved in the pathogenesis 
of intra-amniotic inflammation/infection in preterm delivery (194, 170, 195, 171, 196, 178, 172, 
101, 181, 182, 197, 108), preterm prelabor rupture of the membranes (179, 180, 111, 198-201), 
clinical chorioamnionitis (183), and cervical insufficiency (202-204). In patients with a mid-
trimester short cervix, the concentrations of these cytokines/chemokines in the amniotic cavity 
are correlated with sonographic cervical length (61) and gestational age at delivery (148). In 
addition, all three cytokines are included in the amniotic fluid inflammatory score model, which 
can predict gestational age at delivery (148).  
In the current study, the information obtained from network analysis is of value, since there is 
evidence that suggests that amniotic fluid MCP-1 (also known as CCL-2) and RANTES play a 
role in intra-amniotic inflammation/infection in patients with preterm labor (132, 205, 155, 206), 
preterm prelabor rupture of the membranes (132), a sonographic short cervix (155, 61), 
spontaneous labor at term (207, 208), and histological chorioamnionitis (205).  
Keeler et al. reported that patients with a mid-trimester sonographic short cervix demonstrated 
that an elevation of amniotic fluid MCP-1 concentration (>1500 pg/mL) had 60% sensitivity, 
100% specificity, and a positive predictive value for delivery <34 weeks of gestation (155). 
Moreover, MCP-1 was the most predictive cytokine of spontaneous preterm delivery in patients 
with a mid-trimester short cervix among the other 25 cytokines (155). MCP-1 is capable of 
recruiting macrophages and other leukocytes into sites of inflammation (209-212). Similarly, 
RANTES is a pro-inflammatory chemokine secreted from T cells, which recruit monocytes, 
lymphocytes, basophils, and eosinophils in the host response to inflammation/infection (213-
217). 
Collectively, patients with a sonographic short cervix who subsequently delivered early had a 
more coordinated cytokine network than those who had a late preterm delivery. The ranked 
proteins derived from correlation analysis are informative, have known biological properties 
relevant to parturition, and can be potentially useful in the future for the development of a 
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biomarker pipeline to identify patients with a sonographic short cervix who subsequently deliver 
early. 
 
Inflammatory-related protein network connectivity between patients who delivered ≤32 
and >32 weeks of gestation with a short cervix diagnosed between 26 2/7 and 31 5/7 weeks 
of gestation 
In this interval, the number of perturbed correlations is small (n=5), and none of the 
inflammatory-related protein concentrations differed between patients who delivered early or late 
preterm. However, we found a connection between the antimicrobial peptide lactoferrin and T 
cell–associated cytokines IL-16 and IL-13. Elevated IL-16 and lactoferrin amniotic fluid 
concentrations in women with preterm labor and intra-amniotic infection/inflammation were 
previously reported by our group and others (218-220).  
Gestational age at the diagnosis of a sonographic short cervix and the behavior of the 
cytokine network 
It is known that the earlier the diagnosis of a short cervix is made, the greater the degree of intra-
amniotic inflammation and the earlier the delivery (17-21, 23-27, 30, 61, 62). In addition, Moroz 
et al, reported that in women with a sonographic short cervix (≤25 mm) diagnosed before 25 
weeks of gestation, there was a significant association between cervical shortening and maternal 
systemic inflammation (determined by C-reactive protein) (r2
221
 =0.34, p=0.014). However, this 
association was not observed in patients without a short cervix or a short cervix diagnosed after 
25 weeks of gestation ( ). We present here for the first time that the earlier the occurrence of a 
short cervix, the more orchestrated is the inflammatory response associated with it in women 
who subsequently deliver prior to 32 weeks of gestation. These findings suggest that the risk of 
early spontaneous preterm delivery in asymptomatic women with a sonographic short cervical 
length changes as a function of gestational age at diagnosis and is associated with the magnitude 
and character of the intra-amniotic inflammatory processes characterized by network analysis. 
The importance of study of protein networks in the “great obstetrical syndromes” 
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The improved understanding of the immune response and its soluble mediators (cytokines) 
coupled with the application of molecular biology has led to substantial gains in the description 
of the behavior of multiple inflammatory-related proteins in health and disease. The initial 
emphasis in the study of inflammatory molecules was on the individual changes in the 
concentration and expression of these molecules. This is understandable as discoveries of 
virtually every cytokine occur one at a time. Now, decades later, a more comprehensive and 
detailed map of the protein inflammatory network is available, as well as an improved 
understanding of the nature of the protein-protein interaction and biological function of these 
molecules. A major advance in the understanding of the biology of the inflammatory response is 
that cytokines are organized in complex and redundant networks and the realization that global 
analysis is required to improve insights into the biology and that this approach is superior to a 
simple catalogue in the changes of concentration of individual cytokines. Indeed, the cellular 
response during inflammation represents the interaction between the input derived from several 
cytokines that activate different receptors on the cell surface, leading to generation of several 
intracellular processes. In addition, each cytokine can attach to different receptors on the cell 
surface, and this has implications on the type of cellular response, cellular activation, number 
and profile of cytokine receptors expressed on the cell membrane (222-224). Thus, in order to 
understand the effect of different cytokines an integrative model of cytokine activity is needed. 
There are several reports documenting that information derived from correlation network 
analysis can: 1) improve classification of disease (155, 61, 148); 2) chart the cytokine interaction 
in terms of their effect on specific inflammatory cell types (B and T cells, macrophages) in single 
and multiple cell interactions (223, 224); 3) identify new interfaces between signaling molecules 
in uni- or multi-scale models that incorporates several cell populations (225, 226); 4) be the basis 
of hypothesis generating studies (227); and 5) identify potential therapeutic targets (228, 229). 
This has been the case with breast cancer (157) and chronic fatigue syndrome (230). The 
description of the cytokine network presented herein is novel and may assist in identifying the 
key cytokines involved in the amniotic fluid inflammatory response at different gestational age 
windows which in turn may have diagnostic, prognostic, and therapeutic implications.  
 
Au
th
or
 M
an
us
cr
ip
t
18 
 
This article is protected by copyright. All rights reserved 
Strengths and limitations of the study 
A major strength of the study is that it is the first one to study the inflammatory protein network 
in asymptomatic women at risk for preterm birth because of a sonographic short cervix. Second, 
the study focuses on amniotic fluid, the biological fluid in which major changes in cytokine 
changes are observed in the context of a short cervix. Third, the characterization of the protein 
inflammatory network was not restricted to cytokines, but also included antimicrobial proteins, 
such as lactoferrin, which have been implicated in premature labor. Fourth, the results of the 
cytokine network were unknown at the time of patient management and, therefore, could not 
have biased the clinicians and investigators. As with any other studies, replication of the findings 
is desirable.  
We have characterized for the first time the amniotic fluid pro-inflammatory protein network in 
women with asymptomatic short cervix who are at risk for early preterm birth (<32 weeks of 
gestation). Importantly, the shorter the cervical length, the greater are the perturbations in the 
amniotic fluid inflammatory network, and the higher the risk of early preterm delivery. 
Characterization of the amniotic fluid inflammatory network has implications for the taxonomy 
of disease for patients with a short cervix and identification of those at risk for early premature 
birth.    
Conclusions 
Figure 1: Association between pro-inflammatory protein concentration and cervical length for 
patients diagnosed with a short cervix at 16 5/7 - 22 1/7 weeks gestational age. The figure shows 
the concentration (log
Figure Legends 
2
Figure 2: Three proteins that increase in abundance with cervical shortening at a higher rate in   
women who delivered at ≤32 weeks of gestation (red) compared to those who delivered a t >32 
weeks of gestation (black). As in Figure 1 only patients diagnosed with a short cervix at 16 5/7 - 
, thereof) as a function of cervical length for 4 of the 33 proteins that 
increase with cervical shortening (see Table 2) overall both women who delivered at ≤32 weeks 
of gestation (red) and those >32 weeks of gestation (black).  Au
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22 1/7 weeks gestational age (GA) are included in this analysis. Solid lines represent the best 
linear fit of the log2
Figure 3: Differential correlation analyses. The figure shows log
 protein concentration as a function of GA at amniocentesis. 
2 concentration (pg/mL) of IL-
10 (upper left panel) and MIP1β (upper right panel) as a function of gestational age at 
amniocentesis in patients who had a sonographic short cervix and who delivered ≤32 weeks of 
gestation (red) and those >32 weeks (blue). Dashed lines denote the two tertiles of the 
distribution of gestational age at amniocentesis splitting patients into 3 intervals, and the 
scatterplot of the log2 concentration of IL-10 and MIP1β in the first interval is shown (bottom 
left panel). A linear model was fit to the log2
 
 concentration of each analyte as a function of 
gestational age in each group within each gestational-age interval, and residuals were used to 
compute partial correlations between analytes (bottom right panel). The partial correlation 
between the two analytes was significantly increased in patients who delivered ≤32 weeks of 
gestation than those >32 weeks.       
Figure 4: Network of perturbed cytokine concentration correlations between patients who had a 
sonographic short cervix and who delivered ≤32 weeks of gestation and those who delivered >32 
weeks in the first (left panel, A) and second (right panel, B) gestational-age intervals. Each node 
(sphere) represents one of the 33 analytes, with a link (line) between two nodes representing a 
significantly perturbed correlation. The node color represents the direction of concentration 
change between delivery ≤32 compared to delivery >32 weeks (red=increased, blue=decreased, 
and white=no change), while the color intensity is proportional to the magnitude of concentration 
change. The color of links gives the direction of correlation change (red=increased correlation 
and blue=decreased correlation), while the color intensity is proportional to the magnitude of 
correlation change. The numbers inside/outside the dotted black circle represent the node 
degree/average absolute difference in correlations. 
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Table 1 Clinical and demographic characteristics of the study population 
Variable Overall cohort 
(N = 223) 
Gestational age at delivery p-value* 
≤32 weeks of gestation 
(N = 64) 
>32 weeks of gestation 
(N = 159) 
Maternal age (years) 23.5 (20-28) 25 (21-32.8) 23 (20-27) 0.03 
Pre-pregnancy body mass index 
(kg/m2)** 
25.8 (21.5-32.6) 29.1 (23.0-35.4) 24.7 (21.1-31.0) 0.004 
Race, % (n)    0.64 
African American  91.5% (204) 93.7% (60) 90.6% (144)  
Hispanic 3.1% (7) 3.1% (2) 3.1% (5)  
Caucasian 2.7% (6) 1.6% (1) 3.1% (5)  
Asian 0.9% (2) 1.6% (1) 0.6% (1)  
Other 1.8% (4) 0 2.5% (4)  
Gestational age at amniocentesis 
(weeks) 
24.4 (21.1-27.4) 21.7 (19.9-24.5) 25.4 (22.9-28.4) <0.001 
Sonographic cervical length at 
diagnosis (mm) 
13 (7-18)  7 (2.3-14)  14 (10-19)  <0.001 
Diagnosis 
No intra-amniotic inflammation, % (n) 75.3% (168) 59.4% (38) 81.8% (130) <0.001 
Microbial invasion of the amniotic 
cavity, % (n) 
12.1% (27) 9.4% (6) 13.2% (21) 0.43 
Sterile intra-amniotic inflammation, % 
(n) 
10.3% (23) 25.0% (16) 4.4% (7) <0.001 
Microbial-associated intra-amniotic 
inflammation, % (n) 
2.2% (5) 6.3% (4) 0.6% (1) 0.01 
Intra-amniotic inflammation (ELISA 
IL-6 ≥2.6 ng/mL), % (n) 
12.6% (28) 31.3% (20) 5.0% (8) <0.001 
Treatment 
Cerclage, % (n/N) 8.1% (18/221) 9.4% (6/64) 7.6% (12/157) 0.67 
Progesterone supplementation before 
amniocentesis, % (n/N) 
1.4% (3/214) 0% 2.0% (3/152) 0.27 
Administration of antenatal 
corticosteroids within 7 days before 
amniocentesis, % (n) 
11.7% (26) 12.5% (8) 11.3% (18) 0.80 
Antibiotics before amniocentesis, % (n) 5.8% (13) 6.3% (4) 5.7% (9) 0.87 
Amniotic fluid 
Amniotic fluid IL-6 concentration 0.65 (0.29-1.28) 1.11 (0.31-4.15)  0.59 (0.28-0.99) 0.002 
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(ng/mL)    
Amniotic fluid glucose concentration 
(mg/dL)*** 
30 (25-35) (N=221) 31 (24.3-36) (N=64) 30 (25-35) (N=157) 0.52 
Amniotic fluid white blood cell count 
(cells/mm3)**** 
2 (0-7.5) (N=218) 2 (0-10) (N=63) 1 (0-6) (N=155) 0.06 
Placenta 
Acute inflammatory lesion of placenta, 
% (n/N) 
45.1% (92/204) 73.3% (44/60) 33.3% (48/144) <0.001 
Acute histologic chorioamnionitis, % 
(n/N) 
44.1% (90/204) 73.3% (44/60) 31.9% (46/144) <0.001 
Acute funisitis, % (n/N) 32.4% (66/204) 51.7% (31/60) 24.3% (35/144) <0.001 
Delivery 
Amniocentesis to delivery interval 
(days) 
68 (36-95) 23 (10-35) 85 (64-105) <0.001 
Gestational age at delivery (weeks) 35.7 (30.6-38.7) 26.6 (22.1-29.5) 38.0 (35.1-39.1) <0.001 
Delivery ≥37weeks of gestation, % (n) 44.4% (99) 0% 62.3% (99) <0.001 
Data are given as median (interquartile range) and percent (n) 
*Comparison between patients with a diagnosis of short cervix who delivered before and after 32 weeks of gestation 
**missing data 18 cases, ***missing data 2 cases, ****missing data 5 cases 
ELISA, enzyme-linked immunosorbent assay; IL, Interleukin 
Acute inflammatory lesion of placenta is defined as acute histologic chorioamnionitis and/or acute funisitis 
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Table 2: Changes in protein concentration with cervical shortening 
 
Overall change with CXL Interaction between group and CXL 
Analyte 
Fold 
change
1
 p q 
Fold 
change
2
 p q 
MCP-1  -2.3 0.000 0.000 -2.4 0.003 0.098 
MIP-1a  -2.7 0.000 0.000 -2.7 0.006 0.098 
IL-6  -5.0 0.000 0.000 -4.6 0.009 0.098 
MIP-1b  -3.7 0.000 0.000 -3.5 0.014 0.115 
MIP-3a  -5.4 0.000 0.000 -2.7 0.135 0.735 
HMGB-1  -5.0 0.000 0.000 2.0 0.177 0.735 
I-TAC/CXCL-11  -4.5 0.000 0.000 2.4 0.190 0.735 
Gro-a/CXCL1  -2.5 0.000 0.000 -1.5 0.226 0.735 
Calgranulin C  -2.1 0.041 0.043 -2.5 0.241 0.735 
IL-8  -8.5 0.000 0.000 -4.0 0.241 0.735 
IL-1a  -2.7 0.001 0.001 -2.0 0.273 0.735 
IL-15  -4.3 0.000 0.000 1.9 0.292 0.735 
Eotaxin  -4.2 0.000 0.000 1.7 0.299 0.735 
IL-12  -4.4 0.000 0.000 1.9 0.330 0.735 
RANTES  -2.3 0.004 0.005 1.8 0.334 0.735 
IL-1b  -4.9 0.000 0.000 -1.6 0.392 0.808 
IL-18  -1.4 0.004 0.005 1.2 0.444 0.862 
IL-16  -2.5 0.000 0.000 1.2 0.535 0.897 
IL-10  -4.0 0.001 0.002 -1.7 0.558 0.897 
GM-CSF  -3.0 0.001 0.001 1.5 0.571 0.897 
IFN-g  -3.7 0.000 0.000 1.3 0.658 0.971 
IP-10  -1.4 0.042 0.043 1.1 0.742 0.971 
M-CSF  -3.0 0.000 0.000 1.2 0.749 0.971 
IL-2  -3.9 0.000 0.000 1.1 0.809 0.971 
IL-33  -1.5 0.013 0.014 1.1 0.819 0.971 
IL-7  -6.2 0.000 0.000 1.1 0.846 0.971 
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IL-4  -2.2 0.000 0.000 1.1 0.860 0.971 
IL-13  -6.3 0.000 0.000 -1.1 0.920 0.971 
TGF-b  -7.8 0.000 0.000 -1.1 0.940 0.971 
TNF-a  -4.0 0.000 0.000 1.0 0.942 0.971 
Calgranulin A  -4.8 0.000 0.000 1.1 0.949 0.971 
Lactoferrin  -2.4 0.000 0.000 1.0 0.971 0.971 
 
CXL= Cervix length;  
1
Refers to the change in average protein concentration per cm increase in cervical length. 
Minus sign denotes decrease in concentration with increasing cervical length (or increase with 
cervical shortening). Both groups of patients (delivery<=32 and >32 weeks) were included in 
this analysis.  
2
Refers to the ratio of change in average protein concentration per cm of cervical length in 
patients with delivery at <=32 weeks vs those who delivered at > 32 weeks.  Minus sign denotes 
that the decrease in protein concentration with cervical length (or increase in concentration 
with cervical shortening) is larger in patients who delivered at <=32 weeks compared to those 
who delivered at > 32 weeks. 
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Table 3: Differential protein concentration analysis for different intervals of gestational age at 
amniocentesis 
 
 16.7-22.1 weeks 22.1-26.1 weeks 26.1-31.7 weeks 
Gene FC p q FC p q FC p q 
Calgranulin A 3.8 0.0006 0.002 1.4 0.0382 0.097 -1.2 0.4503 0.803 
Calgranulin C 3.3 0.0023 0.004 1.3 0.4633 0.493 1.4 0.4294 0.803 
Eotaxin 2.4 0.0021 0.004 1.3 0.0937 0.155 1.1 0.5669 0.813 
GM-CSF 2.5 0.0023 0.004 1.3 0.3937 0.433 2.2 0.0686 0.479 
Gro-a/CXCL1 2.2 0.0003 0.001 1.6 0.0058 0.030 1.2 0.3670 0.803 
HMGB-1 3.0 0.0008 0.002 1.8 0.0064 0.030 1.1 0.7594 0.878 
I-TAC/CXCL-
11 2.4 0.0062 0.009 1.4 0.0484 0.114 1.2 0.4836 0.803 
IFN-g 2.4 0.0050 0.008 1.3 0.0942 0.155 1.1 0.7037 0.878 
IL-10 4.4 0.0001 0.000 1.4 0.0650 0.134 1.1 0.6757 0.878 
IL-12 2.9 0.0005 0.001 1.3 0.1875 0.229 1.2 0.5176 0.803 
IL-13 1.9 0.0774 0.088 1.5 0.0884 0.155 1.1 0.7981 0.878 
IL-15 1.8 0.0183 0.023 1.1 0.5204 0.537 1.4 0.1785 0.793 
IL-16 2.8 0.0000 0.000 1.4 0.0361 0.097 -1.0 0.9394 0.969 
IL-18 1.4 0.0231 0.028 1.3 0.0290 0.095 1.3 0.0870 0.479 
IL-1a 2.7 0.0006 0.002 1.2 0.5498 0.550 2.1 0.0721 0.479 
IL-1b 3.0 0.0034 0.006 1.9 0.0193 0.071 1.2 0.5224 0.803 
IL-2 2.0 0.0144 0.020 1.3 0.1661 0.211 1.2 0.3397 0.803 
IL-33 1.8 0.3545 0.354 1.8 0.1050 0.156 1.2 0.6707 0.878 
IL-4 1.9 0.0033 0.006 1.3 0.0935 0.155 -1.2 0.2510 0.793 
IL-6 4.5 0.0002 0.001 4.2 0.0000 0.000 1.0 0.9970 0.997 
IL-7 3.0 0.0020 0.004 1.4 0.1122 0.156 1.2 0.4243 0.803 
IL-8 5.6 0.0003 0.001 5.4 0.0000 0.000 2.3 0.0331 0.479 
IP-10 1.4 0.0881 0.097 1.5 0.1180 0.156 1.2 0.4149 0.803 
Lactoferrin 2.8 0.0000 0.000 1.4 0.0318 0.095 1.6 0.3441 0.803 
M-CSF 2.8 0.0000 0.000 1.3 0.3386 0.385 1.4 0.2240 0.793 
MCP-1 2.4 0.0000 0.000 2.0 0.0027 0.022 1.3 0.2644 0.793 
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MIG 1.4 0.2105 0.217 1.4 0.2975 0.351 -1.1 0.7902 0.878 
MIP-1a 2.9 0.0000 0.000 1.9 0.0075 0.031 1.5 0.0756 0.479 
MIP-1b 5.1 0.0000 0.000 2.6 0.0016 0.018 1.4 0.0860 0.479 
MIP-3a 1.9 0.1479 0.157 1.9 0.0046 0.030 -1.3 0.2384 0.793 
RANTES 1.9 0.0326 0.038 1.4 0.1172 0.156 -1.2 0.5353 0.803 
TGF-b 2.5 0.0167 0.022 1.3 0.1060 0.156 -1.0 0.9385 0.969 
TNF-a 2.4 0.0109 0.016 1.3 0.0592 0.130 1.1 0.7260 0.878 
 
FC=Fold chaŶge. Negatiǀe ǀalues represeŶt decrease iŶ patieŶts deliǀered ≤ϯϮ ǁeeks coŵpared to those 
delivered >32 weeks. p=nominal p-values; q=False Discovery Rate adjusted p-values; Underlined fold 
changes are for proteins for which the differential abundance remains significant if only the patients 
with no intra-amniotic inflammation are used in the analysis. 
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